FROM MITOCHONDRIA TO MOTOR NEURONS FAILURE : MITOPHAGY DYSREGULATION IN <EM>CHCHD10</EM>-ASSOCIATED AMYOTROPHIC LATERAL SCLEROSIS & FRONTOTEMPORAL DEMENTIA
Institute for Research on Cancer and Aging of Nice (IRCAN)
Presentation
Date TBA
Event Information
Poster Board
PS03-08AM-044
Poster
View posterAbstract
Neurons require efficient mitochondrial trafficking and turnover to provide high energy demands. Damaged mitochondria can become toxic and must be removed through mitophagy, a key mitochondrial quality control process.
The identification of the p.S59L variant in the mitochondrial protein CHCHD10 provided the first genetic evidence that mitochondrial dysfunction can trigger motor neuron (MN) disease within the amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) spectrum (Bannwarth et al.,2014). In Drosophila, expression of CHCHD10 p.S59L variant induces chronic activation of PINK1-mediated mitophagy, while PINK1 inactivation rescues mitochondrial network fragmentation (NamChulKim et al.,2021). This project aims to determine whether impaired mitophagy contributes to MN degeneration.
We generated Chchd10S59L/+ mice that reproduce key ALS and FTD features. To visualize mitophagy in vivo, these mice were crossed with MitoQC reporter mice. To go further, mitophagy was analyzed in spinal motor neurons derived from iPSCs of CHCHD10S59L/+ patients.
In Chchd10S59L/+_MitoQC mice, mitophagy was strongly increased in several energy-demanding tissues. In contrast, mitophagy levels in motor neurons and at neuromuscular junctions, two key targets in ALS and FTD, remained unchanged compared to controls. This indicates a selective impaired mitophagy in tissues linked with the pathology. Consistently, patient-derived motor neurons were resistant to both basal and induced mitophagy.
These findings suggest that defective mitophagy in vulnerable tissues may promote the accumulation of damaged mitochondria and contribute to motor neuron degeneration. Ongoing work aims to understand why CHCHD10 p.S59L motor neurons are refractory to mitophagy and whether modulate this pathway could limit neurodegeneration.
Recommended posters
MITOCHONDRIAL PROTEIN AGGREGATION AS A DRIVER OF ALS: SLP2 AND PROHIBITIN PATHOLOGY
Emmanuelle Genin, Françoise Lespinasse, Sylvie Bannwarth, Alessandra Mauri, Gaelle Auge, Erminia Donnarumma, Sandra Lacas-Gervais, Timothy Wai, Luc Dupuis, Véronique Paquis-Flucklinger
CLEARING THE CLUTTER: A NEW PARADIGM OF MITOCHONDRIAL QUALITY CONTROL IN AXONS
Tessa Onraet, Grace Ching Ching Hung, Massimo Hilliard, Steven Zuryn
LONGITUDINAL AUTOPHAGY PROFILING OF THE MAMMALIAN BRAIN REVEALS SUSTAINED MITOPHAGY THROUGHOUT HEALTHY AGING
Anna Rappe, Iné Alvarez van Tussenbroek, Helena A. Vihinen, Fumi Suomi, Homa Ehsan, Antti J. Hassinen, Eija S. Jokitalo, Graham M. Hughes, Sonja C. Vernes, Thomas G. McWilliams
TDP-43 DYSFUNCTION DRIVES CELL-TYPE-SPECIFIC METABOLIC REPROGRAMMING IN MOTOR NEURONS AND MICROGLIA
Ismail Gbadamosi, Zakrzewski Jan, Guntan Ilke, Dymkowska Dorota, Jawaid Ali
MAPPING MITOCHONDRIA-ORGANELLE CONTACT SITES DURING NEURONAL AGEING AND NEURODEGENERATION
Tia Griffiths, Marisa Brini, Tito Calì, Alessio Vagnoni
SUSCEPTIBILITY OF DOPAMINERGIC NERVE TERMINALS TO MITOCHONDRIAL DYSFUNCTION
Maya Faour, Nelson Rebola, Jaime De Juan-Sanz